Direct oral challenge to remove a low-risk penicillin allergy label

被引：0

作者：

Copaescu, A. M. ^{[1
,2
]}

Vogrin, S. ^{[3
]}

James, F. ^{[4
]}

Holmes, N. ^{[4
]}

Chua, K. ^{[4
]}

Rose, M. ^{[4
]}

De Luca, J. ^{[4
]}

Waldron, J. ^{[4
]}

Awad, A. ^{[4
]}

Godsell, J. ^{[4
]}

Mitri, E. ^{[4
]}

Lambros, B. ^{[5
]}

Douglas, A. ^{[5
]}

Khoudja, R. ^{[1
]}

Isabwe, G. ^{[2
]}

Genest, G. ^{[2
]}

Fein, M. ^{[2
]}

Radojicic, C. ^{[6
]}

Collier, A. ^{[6
]}

Lugar, P. ^{[6
]}

Stone, C. ^{[7
]}

Ben-Shoshan, M. ^{[1
]}

Turner, N. ^{[6
]}

Phillips, E. ^{[7
]}

Trubiano, J. ^{[4
]}

机构：

[1] MUHC Res Inst, Montreal, PQ, Canada

[2] MUHC McGill Univ Hlth Ctr, Glen Site, Montreal, PQ, Canada

[3] Univ Melbourne, St Vincents Hosp, Dept Med, Fitzroy, Vic, Australia

[4] Austin Hosp, Heidelberg, Australia

[5] Peter MacCallum Canc Ctr, Melbourne, Australia

[6] Duke Univ, Durham, NC USA

[7] Vanderbilt Univ, Med Ctr, Nashville, TN USA

来源：

ALLERGY | 2023年 / 78卷

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

001400

引用

页码：190 / 191

页数：2

共 50 条

[1] Direct oral challenge for low-risk Penicillin A patients
Samuel, Louise
Mohamed, Omar
Krishna, Mamidipudi Thirumala
Baretto, Richard
CLINICAL AND EXPERIMENTAL ALLERGY, 2024, 54 (10): : 791 - 792
[2] Is direct oral amoxicillin challenge a viable approach for 'low-risk' patients labelled with penicillin allergy?
Krishna, Mamidipudi T.
Misbah, Siraj A.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2019, 74 (09) : 2475 - 2479
[3] The democratization of de-labeling: a review of direct oral challenge in adults with low-risk penicillin allergy
Rose, Morgan Thomas
Slavin, Monica
Trubiano, Jason
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2020, 18 (11) : 1143 - 1153
[4] Inpatient allergy delabeling of pediatric patients with low-risk penicillin allergy status through direct oral amoxicillin challenge
Lim, Peter Paul C.
Moore, LeAnne N.
Minich, Nori Mercuri
Wessell, Kathryn Ruda
Desai, Ankita P.
ALLERGY AND ASTHMA PROCEEDINGS, 2024, 45 (01) : 61 - 69
[5] In low-risk penicillin allergies, direct oral challenge was noninferior to skin testing followed by oral challenge
Aung, Koko
Htay, Thwe
ANNALS OF INTERNAL MEDICINE, 2023, 176 (11) : JC127 - JC127
[6] Direct Oral Challenge is a Safe and Effective Strategy to Delabel Low-Risk Penicillin Allergy in Immunocompromised Patients Admitted to the ICU
Koo, Grace
Stollings, Joanna
Lindsell, Christopher
Lynn, Mary
Kripalani, Sunil
Phillips, Elizabeth
Stone, Cosby
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB79 - AB79
[7] Risk-stratified Management to Remove Low-Risk Penicillin Allergy Labels in the ICU
Stone, Cosby A., Jr.
Stollings, Joanna L.
Lindsell, Christopher J.
Dear, Mary Lynn
Buie, Reagan B.
Rice, Todd W.
Phillips, Elizabeth J.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201 (12) : 1572 - 1575
[8] Low-risk penicillin allergy delabeling through a direct oral challenge in immunocompromised and/or multiple drug allergy labeled patients in a critical care setting
Koo, Grace
Stollings, Joanna L.
Lindsell, Christopher
Dear, Mary Lynn
Kripalani, Sunil
Nelson, George E.
McCoy, Allison B.
Rice, Todd W.
Phillips, Elizabeth J.
Stone, Cosby A., Jr.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (06): : 1660 - +
[9] Low-risk penicillin allergy delabeling: a scoping review of direct oral challenge practice, implementation, and multi-disciplinary approaches
Mitri, Elise
Reynolds, Gemma
Hornung, Catherine J.
Trubiano, Jason A.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2024, 22 (1-3) : 59 - 69
[10] Oral amoxicillin challenge for low-risk penicillin allergic patients
Livirya, Silabhakta
Pithie, Alan
Chua, Ignatius
Hamilton, Niall
Doogue, Matthew
Isenman, Heather
INTERNAL MEDICINE JOURNAL, 2022, 52 (02) : 295 - 300

← 1 2 3 4 5 →